Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
4 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Yesterday
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.

Mindfulness promotes better sleep in fibromyalgia patients

04 Apr 2020

Among patients with fibromyalgia, practicing mindfulness may alleviate pain, depression and anxiety, thereby conferring benefits for sleep, a study has found.

Researchers looked at 177 fibromyalgia patients (mean age, 52.0 years; 93 percent female; body mass index, 30 kg/m2) and measured mindfulness (Five Facet Mindfulness Questionnaire [FFMQ]), sleep quality and disturbance (Pittsburgh Sleep Quality Index [PSQI], PROMIS Sleep Disturbance [PROMIS‐SD]), pain interference (PROMIS Pain Interference), and anxiety and depression (Hospital Anxiety and Depression Scale).

The mean disease duration of the population was 13.1 years. The mean total FFMQ score was 131.3, with mean scores ranging from 21.7 to 29.5 across the five individual facets of mindfulness.

Higher mindfulness was significantly associated with better sleep quality (PSQI, p=0.002), less sleep disturbance (PROMIS‐SD, p=0.002), lower pain interference (p<0.0001), and reduced anxiety (p<0.001) and depression (p<0.0001).

The relationship between mindfulness and sleep quality was mediated by pain interference, depression and anxiety.

The results highlight the importance of developing multimodal therapeutic strategies influencing multiple clinical characteristics, including mindfulness and psychosocial factors, to improve sleep quality for individuals with fibromyalgia, according to the researchers. 

More studies are needed to investigate the causality and directionality of the observed relationships and should consider measuring change in mindfulness to evaluate its longitudinal effect on sleep in fibromyalgia populations, they added.

Editor's Recommendations
Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
4 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Yesterday
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.